Neurogen To Try Adipiplon In Crossover Study With Ambien
This article was originally published in The Pink Sheet Daily
Executive Summary
Anxiety, schizophrenia studies also part of broad effort to develop GABA-based insomnia agent.
You may also be interested in...
Neurogen Raises Cash, Cuts Staff
Lead candidate for insomnia targets “lifestyle” market, pharmacist tells “The Pink Sheet” DAILY.
Neurogen Raises Cash, Cuts Staff
Lead candidate for insomnia targets “lifestyle” market, pharmacist tells “The Pink Sheet” DAILY.
Neurogen Will Advance Insomnia Drug Based On Positive Top-Line Phase IIb Results
Improved specificity will make NG2-73 first-line therapy of choice for the vast majority of insomnia sufferers, Neurogen R&D chief says.